Principal Financial Group
AGN

Principal Financial Group’s Allergan Inc AGN Stock Holding History

Principal Financial Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-383,860
Closed -$81.6M – 2262
2014
Q4 		$81.6M Buy
383,860
+11,048
+3% +$2.2M 0.13% 206
2014
Q3 		$66.4M Buy
372,812
+5,485
+1% +$911K 0.11% 227
2014
Q2 		$62.2M Buy
367,327
+2,527
+0.7% +$393K 0.1% 241
2014
Q1 		$45.3M Buy
364,800
+4,345
+1% +$529K 0.08% 288
2013
Q4 		$40M Buy
360,455
+5,151
+1% +$492K 0.07% 303
2013
Q3 		$32.1M Buy
355,304
+4,430
+1% +$398K 0.07% 328
2013
Q2 		$29.6M Buy
+350,874
New +$36.4M 0.07% 332

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Principal Financial Group's AGN Position: Q1 2015 in Review

Principal Financial Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 383,860 shares — an estimated $81.6M sold.

Principal Financial Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $81.6M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Principal Financial Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Principal Financial Group sold 383,860 Allergan Inc shares in Q1 2015, an estimated $81.6M.
  • Principal Financial Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Principal Financial Group's Allergan Inc position peaked at $81.6M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Principal Financial Group's 13F filing for Q1 2015, filed 12 May 2015.